Received grant in 2020
DCCC has funded 153,124 DKK to the project.
The project will uncover potential barriers for equal use of proton therapy for Danish patients with head and neck cancer. The treatment is centralized in one clinic in Denmark and for patients with head and neck cancer only available in clinical trials.
The study will demonstrate the demographic, socioeconomic and clinical factors with potential impact on inequality in acceptance of enrollment in clinical trials and subsequent referral for a nationally centralized treatment. In light of the obtained knowledge, national initiatives will be developed to support equal access to proton therapy.
Multidisciplinary organisation
The Danish Centre for Particle Therapy, DAHANCA (Danish Head and Neck Cancer Group), DCCC Radiotherapy and Danish Research Centre for Equity in Cancer (COMPAS)
Project stakeholders
- Anne Wilhøft Kristensen, Clinical Nurse Specialt, Danish Center for Particle Therapy, Aarhus University Hospital. Primary contact, Mail: annkrs@rm.dk
- Cai Grau, Professor, MD, DMSc, Department of Oncology & Danish Center for Particle Therapy, Aarhus University Hospital and Head of DCCC Radiotherapy
- Susanne Dalton, Professor, Head of Research Group ‘Social Inequality in Cancer’ Danish Cancer Society Research Center (DCRC), Copenhagen & head of COMPAS, Danish Research Center for Equality in Cancer, Zealand University Hospital
- Kenneth Jensen, MD, Danish Center for Particle Therapy, Aarhus University Hospital
- Annesofie Lunde Jensen, Clinical Nurse Specialist, post.doc, Department of Medical Endocrinology and Internal Medicine, Aarhus University Hospital
- Jeppe Friborg, MD, Department of Clinical Oncology, Rigshospitalet
- Elo Andersen, MD, Department of Oncology, Herlev University Hospital
- Maria Andersen, MD, Department of Oncology, Aalborg University Hospital
- Mohammad Farhadi, MD, Department of Oncology, Zealand University Hospital
- Jørgen Johansen, MD, Department of Oncology, Odense University Hospital
- Jesper Eriksen, MD, Professor, Department of Oncology, Aarhus University Hospital